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Abstract. In this paper, we present a novel real-time cancer detection technique by using needle insertion 
forces in conjunction with patient-specific criteria during percutaneous interventions. Needle insertion 
experiments and pathological analysis were performed for developing a computer-aided detection (CAD) 
model. Backward stepwise regression method was performed to identify the statistically significant 
patient-specific factors. A baseline force model was then developed using these significant factors. The 
threshold force model that estimated the lower-bound of the cancerous tissue forces was formulated by 
adding an adjustable classifier to the baseline force model. Trade-off between sensitivity and specificity 
was obtained by varying the threshold value of the classifier, from which the receiver-operating 
characteristic (ROC) curve was generated. Sequential Quadratic Programming (SQP) was used to optimize 
the CAD model by maximizing the area under the ROC curve (AUC) using a set of model-training patient 
data. When the CAD model was evaluated using an independent set of model-validation patient data, an 
AUC of 0.90 was achieved. The feasibility of cancer detection in real time during percutaneous 
interventions was established.  
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Background 
Prostate cancer is the second leading cause of male cancer death in Europe and North 
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America. In 2008, the National Cancer Institute (NCI) estimated that there would be 
186,320 new prostate cancer cases in the United States, and about 28,660 persons would 
die from prostate cancer1. With the advent of prostate-specific antigen (PSA) screening, a 
majority of prostate cancers is diagnosed in the early stages. Of the various modalities of 
therapy, interstitial needle delivery of therapy such as brachytherapy is being increasingly 
used.  
The needle-tissue interaction forces during percutaneous intervention have been a 
focus of research interests in the past several years2-10. For instances, needle insertion 
forces have been measured in tissue-like phantoms2,3, ex-vivo human and animal organ 
samples4,5, in-vivo animal experiments6 and in-vivo prostate brachytherapy procedures7. 
The influence of needle coating3, needle tip shape and insertion velocity8, and 
patient-specific factors9,10 on the magnitude of insertion force was investigated as well. 
An extensive literature survey on needle-tissue interaction can be found in Ref. 11. The 
main objective of these studies was to predict or control the insertion force during 
penetration, so that more accurate needle placement and less tissue deformation can be 
achieved. The techniques in distinguishing different tissues (e.g. tumor vs. normal tissue) 
by analyzing the needle-tissue interaction forces have been largely neglected. 
Studies in the literature have shown that when tissues become diseased, changes in 
tissue composition, consistency, elasticity and stiffness will occur. Some researchers 
analyzed prostate tissue in vitro and showed that there were variations in stiffness 
between tumor and normal tissue12. There were also variations between patients13. In 
general, tumors resulting from abnormal and excessive cell division are harder than the 
normal healthy tissues. Therefore, tumors can be detected as hard lumps13. 
Sonoelastography, which is an ultrasound imaging technique relying on color Doppler 
information from the forced vibration of soft tissues where a hard inhomogeneity (such as 
a tumor) can produce a localized disturbance in the vibration pattern, has been developed 
to detect hard lesions in relatively soft tissue14-16. 
In this paper, we present a real-time technique for cancer detection using the needle 
insertion forces and patient-specific criteria (e.g. patient age, ethnicity, prostate density, 
and PSA, etc.). To the authors’ best knowledge, this is the first study in the reported 
literature to use the insertion force for cancer detection purpose. The proposed technique 
is developed as a candidate for robotic brachytherapy with real-time force sensing and 
intraoperative planning to achieve dose painting, so that the dose to malignant tumors can 
be escalated while nominal or even de-escalated dose may be delivered to non-suspicious 
tissues.  
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2 Materials and Method 
2.1 Needle insertion experiment using ex-vivo human prostate 
A total of 23 prostate samples were collected from patients who underwent radical 
prostatectomy in an Institutional Review Board (IRB) approved clinical study and with 
the patients’ informed consent. Only 21 patients’ data were used for analysis. Two 
patients were excluded from the present analysis due to either lack of patient-specific 
data or pathological data. Each sample was brought to the laboratory within 10 minutes 
of completing the surgical excision. The prostate sample was placed into a 
polyvinylchloride (PVC) phantom prepared before-hand (see Fig. 1 (a)). Two 
stabilization needles were used to mimic the scenario during the actual brachytherapy 
procedure. A set of 18-gauge diamond tip prostate brachytherapy needles (Mick 
Radio-Nuclear Instruments, Inc., NY) were used throughout the whole set of 
experiments. A 6 degrees-of-freedom (DOF) robotic system equipped with a 6 DOF 
force-torque (F-T) sensor (Nano17®, ATI Industrial Automation, NC) was used to drive 
the needle into the prostate. The needle was inserted at a constant speed of 5 mm/s at 10 
locations in three zones that were defined empirically, i.e. peripheral zone (the posterior 
portion of the prostate), central zone (the inner portion of the prostate) and transitional 
zone (the area immediately surrounding the urethra), as shown in Fig. 1 (b). Force-torque 
data were collected for analysis during the procedure. After the insertion experiment, the 
prostate sample was immediately sent to the surgical pathology laboratory for 
histological analysis. The prostate was sliced from apex to base at a thickness of 5 mm. In 
each histological slice, a total of 10 locations around the needle insertion positions (one 
location for each needle) were identified and marked by the surgical pathologist (L. Li). 
The diagnosis was recorded in a pathology report describing the histological findings, 
which served as the ground truth in the following study for determination of the actual 
tissue characteristics (e.g. tumor or normal tissue).  
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Fig. 1: Experimental setup (a) experimental platform; (b) distribution of needle insertions. The two 
ultrasound probes in the figure were used to capture the needle insertion procedure for post-evaluation, i.e. 
tissue deformation, needle bending, etc. 
 
2.2 Identification of statistically significant patient-specific factors 
The patient-specific factors under consideration included patient age, ethnicity, Body 
Mass Index (BMI), clinical stage, PSA, Gleason Sum obtained from biopsy, prostate 
volume measured from the radical prostatectomy specimen, and prostate density 
calculated from measured prostate volume and weight. These factors may relate to the 
mechanical properties of the prostate tissue, thus influencing the insertion forces. Since 
the needle force was a function of insertion depth, and may also be characterized by 
different zones, for simplicity, mean forces at the same insertion depth in the same zone 
were compared. 
To determine the significance of these factors on the insertion force, backward 
stepwise regression was used: starting with all the terms in the model, the least significant 
terms were sequentially removed until all the remaining terms were statistically 
significant. The p-values that represent the significance of the factors, and variance 
inflation factors (VIF) that are measure of the multicolinearity in a regression design 
matrix (i.e., the independent variables)14, were evaluated for selection of the statistically 
significant factors. A p-value close to zero means that the parameters under testing are 
statistically significant and thus should be kept in the model. Here we chose p=0.05 as the 
cutoff value. For VIF, both 5 and 10 have been used in the literature as a critical 
threshold as a rule of thumb17. These VIF values correspond to R2 (coefficient of 
determination) values of 0.8 and 0.9, respectively. Here considering the small size of 
dataset, 5 was selected; that is, if VIF was larger than 5, then multicollinearity was high. 
Durbin-Watson number was also examined to detect autocorrelation in the model 
residuals. A value around 2 generally indicates that there appeared to be no 
autocorrelation, e.g. the models are properly specified and no significant information is 
left with the residuals. Considering the influence of the sample size and the number of 
statistically significant factors in the model, this statistic was compared with tabulated 
rejection values as shown in J.Durbin, et al18, which were calculated based on those effects. 
 
2.3 Tumor classification model optimization  
The baseline model that estimates the mean force values in normal tissue can be 
represented using the equation as shown below. 
                                    
0
i
i
N
n
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where iX is the i
th
 statistically significant patient-specific factor; β i is the corresponding 
coefficient vector; ni is the order of iX ; N is the number of the statistically significant 
terms. 
Thus the threshold force model that measures the lower bound of the cutoff force 
values in cancerous tissue can be represented as 
 t bF F= + ∆              (2) 
where ∆ , named ‘classifier’, represents the estimated force difference between the 
cancerous tissue and the normal tissue. Forces equal to or higher than the threshold force 
will indicate the existence of cancerous tissue. Selecting different values of ∆  has the 
effect of selecting different trade-offs between sensitivity and specificity. The AUC, 
which aggregates the performance across the range of trade-offs (sensitivity and 
specificity) and is independent of the chosen classifier∆ , is of primary consideration for 
model optimization. 
The optimization problem can be represented mathematically as 
                     Max {( ), ( , ) ( ) 0, 0,1, }i cn g i Nθ θ β θ= ∈Φ= ≤ = KF     (3) 
where 

F  represents objective ‘AUC’, which can be calculated by integrating the area 
under the ROC curve. Here we define bounds or constraints to the parameters based on a 
priori information to improve the search efficiency. For example, if the relationship 
between certain statistically significant factor and needle insertion force is known either 
empirically or from factorial study, a constraint will be set for that factor during 
optimization. Here, Φ is the feasible domain where the parameters satisfy all the 
constraints; ( )g θ is the defined constraint function, and Nc is the number of constraints. 
Thus, this is a case of constrained optimization problem. 
In constrained optimization, a commonly used method is to transform the problem 
into an easier sub-problem that can then be solved and used as the basis of an iterative 
process. Some of the main techniques that have been proposed for solving constrained 
optimization problems are reduced gradient methods19, sequential linear and quadratic 
programming (SQP) methods20, and augmented Lagrangians and exact penalty functions 
method21. The SQP method, which represents the state of the art in the nonlinear 
programming methods, has been used in this study. This method generates a Quadratic 
Programming (QP) sub-problem by replacing the objective function with the quadratic 
approximation, and the constraint functions with linear approximations, as shown in Eq. 
(4). The QP algorithm is used to calculate a feasible point and form a new iteration (Eq. 
(5)). Then the Hessian Matrix H in Eq. (4) is updated using Broyden-Fletcher-Goldfarb- 
Shanno (BFGS) algorithm (Eq. (6)), which leads to the update of the sub-problem in a 
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new iteration until satisfactory convergence is achieved22. The detailed algorithm is 
illustrated in Fig. 2, in which r represents the penalty parameter that is updated using Eq. 
(7) in each iteration.  
1 ( )
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where the matrix H  is a positive definite approximation of the Hessian matrix of the 
Lagrangian function; ′

F  is obtained by multiplying 

F  with a negative sign; d is the 
search direction; kα is a scalar step-length parameter determined by the line search 
procedure, so that a sufficient decrease in a merit function is obtained; iλ  is the 
Lagrange multipliers. As a starting point, x0 can be initialized to any vector that agrees 
with the constraints; H0 is then a positive definite approximation to the inverse of the 
Hessian at x0; r0 can be initialized using Eq. (8)23.  
                      0
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g x
∇
=
∇
                  (8) 
where  represents the Euclidean norm. 
 
Fig. 2: Flow chart of SQP implementation. 
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3 Results 
3.1 Insertion force analysis 
During the needle insertion experiment, the needle was inserted into the prostate 
from the apex to the base. At the beginning, the needle was accelerated to 5 mm/s by the 
robotic system. After the needle touched the prostate, the prostate first deformed and the 
force increased before the needle punctured through the capsule. The puncture point can 
be identified by the sudden drop of the insertion forces. After puncture, the needle moved 
inside the prostate until it quickly decelerated to stop. Figure 3 shows typical force 
profiles at the three zones in one of the patients. During the experiment, either failure of 
puncture (e.g. insertion 7 and 8) or late puncture (e.g. insertion 6) could happen due to the 
resistance of the prostate capsule, or prostate translation or even rotation during the 
insertion procedure. In the entire set of experiments, a total of 59 insertions (28.1% of 
total insertions) were found to either fail in insertion into the prostate, or could not be 
associated with the puncture points from both the force plot and the experimental records. 
Most of the insertion failures happened in the peripheral zone mainly due to the fact that 
the needle insertions in this zone induced the most unbalanced forces for the prostate, 
thus causing the prostate to rotate and increasing the difficulties of the needle insertion. 
This high failure rate would be greatly reduced in actual brachytherapy procedures since 
the in-vivo prostate would be better supported from the surrounding connective tissues as 
compared to the prostate specimen setup during the experiment. In the transitional zone, 
there was a higher likelihood of encountering the urethra, which was relatively harder 
than the prostate tissue and could result in increased force, thus constituting great 
disturbance for force analysis. In some cases, the needles were even deflected when 
inserting into the urethra. Thus in the current study, we mainly focused on analyzing the 
forces in the central zone, where sufficient numbers of successful needle insertions (70 
insertions) were available for analysis.  
The needle insertion forces inside the prostate mainly came from the tissue cutting 
and viscoelastic frictional forces. Under the same experimental conditions (needle 
geometry, insertion speed, etc.), the variation of the magnitude of the forces can be used 
as an indicator of tissue composition variability along the needle path. Figure 4 shows an 
example of needle insertion forces inside the normal tissue vs. the tumor. As can be 
observed from the figure, the tumor required a larger force (compressive force is 
represented by negative sign) to pass through. Comparison of the absolute mean insertion 
forces through the cancerous tissue with those through the normal tissue revealed that the 
former was larger than the latter by 0.7 N to 2.2 N (see Fig. 5), which could be explained 
by the increased hardness of the cancerous tissue12,16. In our 21 cases (70 insertions), only 
11 cases (38 insertions) that had insertions passing through both the cancerous tissue and 
normal tissue were included for comparison. The mean forces of all the individual 
insertions passing through the same type of tissues (tumor and normal tissue) in the same 
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patients were calculated and compared. Table 1 presents the statistical summary. The 
small p value (<0.01) obtained from Analysis of Variance (ANOVA) indicates that the 
force variance between the cancerous and normal tissue is significant. In addition, as 
shown in Fig. 5, the mean forces from different patients are shown to be different even in 
the same type of tissue. In the following section, we investigated the statistically 
significant patient-specific factors (i.e., patient age, ethnicity, prostate volume, prostate 
density, PSA level, and so on), which may contribute to the force variances. 
  
 
 
 
Fig. 4: An example of forces through normal tissue vs. tumor. 
 
Fig. 3: Typical force profiles in 
(a) central zone (b) transitional 
zone (c) peripheral zone of the 
prostate. 
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Fig. 5: Comparison of mean forces (absolute values) in the cancerous tissue and normal tissue at 
central zone. 
 
 
3.2 Statistically significant patient-specific factors 
A total of six iterations were performed using data from the 70 insertions until a 
model with only significant factors was obtained. The final result reveals that prostate 
density and PSA have significant effects on the mean forces. The p-value less than 
0.0001 suggests that the regression model is significant. Durbin-Watson value at 1.94, 
being larger than 1.161, which is the cutoff value for 2 regressors (excluding the intercept) 
and 21-sample size18, indicates no autocorrelation. In the regression model, the force 
monotonically increases with density and PSA; this reveals that larger prostate density 
and higher PSA level tend to produce larger insertion forces. The relationships between 
needle insertion force and prostate density, as well as PSA are used as constraints for the 
selection of the parameters during optimization, which will be discussed in the next 
section.  
3.3 Optimal baseline model with simulation results 
The optimization engine has been implemented in MATLAB (MathWorks, Inc., 
MA). Experimental data from 10 patients were selected for modeling. The selection of 
patients for model prediction was based on factorial design24, where the patient-specific 
factors in the selected modeling dataset should cover the lowest and highest levels of the 
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corresponding factors in the entire dataset. Pathological data were used as ground truth to 
measure the correctness of the cancer detection method, from which sensitivity and 
specificity were computed. Previous regression study in Section 3.2 has shown that the 
first-order linear model was sufficient for the current small dataset (p-value <0.0001). 
Thus the order of the baseline model (ni) was set to be ‘1’ for simplicity. In the future, 
with more data available, the order should also be optimized. In addition, the regression 
analysis indicates that the force monotonically increases with density and PSA. Therefore, 
the feasible domain for the parameters of both density and PSA was constrained to half 
Cartesian space, where the parameters had the same negative signs as the force. These 
two constraints were used in the optimization procedure. 
The optimization algorithm was run with the parameter vector initialized at [-0.10; 
-0.70; -0.10], which represented the constant and parameters of density and PSA 
respectively. The resulting optimal parameter vector was [-0.06; -0.06; -0.175], with 
which the maximum AUC was achieved at 0.80. As comparison, for a force model 
without patient-specific factors, the maximum AUC achievable was 0.55. Similarly, for a 
model with density or PSA only, the maximum AUCs achievable were 0.59 and 0.75, 
respectively. This demonstrates that characterizing the insertion force using the 
statistically significant factors will result in better estimation. 
 The model was then validated using the remaining 11 patients’ data. By varying the 
classifier values in increments of 0.2, an ROC curve was generated, as shown in Fig. 6. 
The AUC calculated using this independent set of validation data was equal to 0.90. With 
classifier of 1.7, sensitivity of 100% and specificity of 76% can be achieved, while with 
classifier of 1.9, sensitivity of 86% and specificity of 79% can be achieved. Figure 7 
shows the absolute mean insertion forces in the central zone (N2, N5, N7, N9) for all 21 
patients, together with the estimated baseline forces and the thresholds after applying 
classifier of 1.7.  
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Fig. 6: ROC curve. 
 
 
Fig. 7: Needle insertion forces in central zone of the prostate with generated baseline forces and 
thresholds using classifier 1.7. The red arrows point to the ones with cancer. 
 
 
4. Discussions 
As can be observed from Fig. 7, the majority of the cancers could be detected with a 
classifier of 1.7. Some false cancer detections resulted for the following reasons. Firstly, 
the present baseline force model included two patient-specific factors: prostate density 
and PSA values. Other factors such as Gleason score, cancer stage, etc. may also have an 
influence on the force model. In the present small dataset, these factors were not found to 
be statistically significant, probably due to the narrow variances of their values, as shown 
in Table 2, thus resulting in insignificant changes of the corresponding forces. The use of 
a constant mean (-0.06) for the uncharacterized force part would result in errors in 
predicting the baseline force. The solution to improve the baseline force model would be 
to expand the study with more patients’ data to further investigate and identify the 
statistically significant patient-specific factors. 
Another reason for incorrect diagnoses may come from experimental procedure 
errors. For example, insertion forces in patient #17 were high due to significant prostate 
movement during needle insertion. Potential approaches to overcome this problem 
include better immobilization of the prostate specimens. In some other cases, high 
composition of fibromuscular (FM) component ( ≥ 80%) (e.g. N7 in patient #2) or 
occurrence of benign prostatic hyperplasia (BPH) (e.g. N9 in patient #17), would also 
result in higher insertion forces as compared to other insertions in the same patient, thus 
leading to the wrong diagnosis. A multi-modal method that combines this technique with 
other tissue characterization techniques (e.g. ultrasound tissue characterization25 or 
Acoustic Radiation Force (ARF) sono-contrast technique26) may help improve cancer 
discrimination specificity. 
One concern in applying the current model is how to estimate the prostate density 
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in-vivo. Some potential techniques could be via imaging methods, such as relying on 
carefully calibrated CT densities, or replacing density with other similar, surrogate 
patient-specific criterion, e.g. tissue elasticity measured using imaging techniques27, 
which may be considered in the future. One limitation of the proposed cancer detection 
methodology is that it can only detect tumor foci along the needle insertion trajectory. 
In the current study, we had 21 patients’ data, of which 10 patients’ data were used 
for model construction and 11 patients’ data were used for model validation. For the 
modeling set, the mean force is -2.92 N with standard deviation of 1.12 N, and there are 9 
cancers in the dataset; while for the testing set, the mean force is -2.74 N with standard 
deviation of 0.77 N, and there are 7 cancers in the dataset. Wilcoxon rank sum test28 of 
the two datasets for equal medians gave a p value of 0.90, which suggests that the two 
independent datasets come from identical distributions. This demonstrates that the 
selection of the datasets is not biased. Additional patient data will be helpful for better 
‘training’ of the baseline force model and further evaluating the proposed methodology. 
We classified the whole prostate into three (peripheral, central and transitional) zones and 
intended to build a model for each zone separately. Due to insufficient number of 
successful insertions passing through both tumor and normal tissue in the peripheral and 
transitional zones, only forces in the central zone were studied. The other two zones, 
especially the peripheral zone where most cancers tend to develop, will be studied in the 
future. Also in the current model, only patient-specific factors were included. 
Procedure-related factors (needle insertion speed, insertion depth, needle size, etc.) were 
not included. In the future, we will use different types of needles with various insertion 
speeds, and improve prostate specimen immobilization, so that the procedure-related 
factors can be included in the model. 
 
 
 
 
5. Conclusions 
In this paper, a novel approach for real-time cancer detection using needle insertion 
force has been presented. After parameter optimization using data from 10 patients, the 
technique achieved an AUC of 0.90 when evaluated using an independent set of 
validation data from another 11 patients. The feasibility of cancer detection in real time 
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during interstitial interventions is established. The proposed technique is intended to be 
used in robotic brachytherapy with real-time force sensing and dynamic planning to 
achieve targeted therapy. Other potential applications include biopsy, photodynamic 
therapy and thermal ablation. 
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